Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer
- PMID: 36147929
- PMCID: PMC9486401
- DOI: 10.3389/fonc.2022.971479
Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer
Abstract
Ovarian cancer is an aggressive tumor that remains to be the most lethal gynecological malignancy in women. Metabolic adaptation is an emerging hallmark of tumors. It is important to exploit metabolic vulnerabilities of tumors as promising strategies to develop more effective anti-tumor regimens. Tumor cells reprogram the metabolic pathways to meet the bioenergetic, biosynthetic, and mitigate oxidative stress required for tumor cell proliferation and survival. Oxidative phosphorylation has been found to be altered in ovarian cancer, and oxidative phosphorylation is proposed as a therapeutic target for management of ovarian cancer. Herein, we initially introduced the overview of oxidative phosphorylation in cancer. Furthermore, we discussed the role of oxidative phosphorylation and chemotherapeutic resistance of ovarian cancer. The role of oxidative phosphorylation in other components of tumor microenvironment of ovarian cancer has also been discussed.
Keywords: metabolic reprograming; mitochondria; ovarian cancer; oxidative phoshorylation; resistance.
Copyright © 2022 Wu, Zhang, Wang, Zheng, Cao and Shen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.Mol Oncol. 2017 May;11(5):491-516. doi: 10.1002/1878-0261.12046. Epub 2017 Apr 3. Mol Oncol. 2017. PMID: 28236660 Free PMC article.
-
Metabolic dependencies and targets in ovarian cancer.Pharmacol Ther. 2023 May;245:108413. doi: 10.1016/j.pharmthera.2023.108413. Epub 2023 Apr 13. Pharmacol Ther. 2023. PMID: 37059310 Review.
-
Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer.Cancers (Basel). 2018 Sep 18;10(9):337. doi: 10.3390/cancers10090337. Cancers (Basel). 2018. PMID: 30231564 Free PMC article. Review.
-
Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma.Front Oncol. 2023 Jun 8;13:1141851. doi: 10.3389/fonc.2023.1141851. eCollection 2023. Front Oncol. 2023. PMID: 37361580 Free PMC article. Review.
-
Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities.Front Oncol. 2022 Jun 8;12:816504. doi: 10.3389/fonc.2022.816504. eCollection 2022. Front Oncol. 2022. PMID: 35756631 Free PMC article. Review.
Cited by
-
Hydrophobic surface induced pro-metastatic cancer cells for in vitro extravasation models.Bioact Mater. 2024 Jan 8;34:401-413. doi: 10.1016/j.bioactmat.2023.12.021. eCollection 2024 Apr. Bioact Mater. 2024. PMID: 38282966 Free PMC article.
-
Ferroptosis, Metabolic Rewiring, and Endometrial Cancer.Int J Mol Sci. 2023 Dec 20;25(1):75. doi: 10.3390/ijms25010075. Int J Mol Sci. 2023. PMID: 38203246 Free PMC article. Review.
-
Ovarian Cancer: A Landscape of Mitochondria with Emphasis on Mitochondrial Dynamics.Int J Mol Sci. 2023 Jan 8;24(2):1224. doi: 10.3390/ijms24021224. Int J Mol Sci. 2023. PMID: 36674740 Free PMC article. Review.
-
Independent organelle and organelle-organelle interactions: essential mechanisms for malignant gynecological cancer cell survival.Front Immunol. 2024 Apr 22;15:1393852. doi: 10.3389/fimmu.2024.1393852. eCollection 2024. Front Immunol. 2024. PMID: 38711526 Free PMC article. Review.
-
Mutational profiling of mitochondrial DNA reveals an epithelial ovarian cancer-specific evolutionary pattern contributing to high oxidative metabolism.Clin Transl Med. 2024 Jan;14(1):e1523. doi: 10.1002/ctm2.1523. Clin Transl Med. 2024. PMID: 38193640 Free PMC article.
References
-
- Dey P, Kimmelman AC, DePinho RA. Metabolic codependencies in the tumor microenvironment. Cancer Discovery (2021) 11(5):1067–81. doi: 10.1158/2159-8290.CD-20-1211 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources